2022 Breakthroughs in Ovarian Cancer Research and Treatment
“We are truly in the Golden Age, the Renaissance, if you will, of care for people with ovarian cancer. So much is happening.” Dr. Stephanie Blank Though there is still … Continued
News
The Overview | December 2022
There are many different celebrations involving light during these dark winter days. And certainly, our community is a great source of brightness — from the hope of scientific breakthroughs on … Continued
Amrita Salvi, PhD | Meet a Scientist
Dr. Amrita Salvi, of University of Illinois at Chicago, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Investigating the Mechanism of Action of PHY34 in HGSOC,” … Continued
Zelei Yang, PhD | Meet a Scientist
Dr. Zelei Yang, of Dana Farber Cancer Institute, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Re-engaging the Anti-tumor Immune Response Against Ovarian Cancer,” Dr. Yang … Continued
Gamze Bildik Elcik, PhD | Meet a Scientist
Dr. Gamze Bildik Elcik, postdoctoral fellow in the Department of Experimental Therapeutics at MD Anderson Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “DIRAS3 … Continued
New Research Points to Persistent Racial Disparities in Ovarian Cancer Care
Recent research published in JNCCN–Journal of the National Comprehensive Cancer Network has shown that there are clear disparities when it comes to which ovarian cancer patients are receiving treatment in accordance with … Continued
Erin Wesley, PhD | Meet a Scientist
Dr. Erin Wesley, of University of Minnesota Twin Cities, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Impact of Cytomegalovirus and Inflammation on NK Cells in … Continued
Germline vs Somatic Testing; Genomic vs Genetic Testing — What it Means and Why it Matters
NCCN guidelines for the management of ovarian cancer, as well as fallopian and primary peritoneal cancers, specify that patients diagnosed with those diseases should have germline and somatic testing. But … Continued
FDA Approves Mirvetuximab Soravtansine-Gynx for Treatment of Platinum-Resistant Ovarian Cancer
In exciting treatment news, the Food and Drug Administration (FDA) has granted accelerated approval to mirvetuximab soravtansine-gynx (trade name Elahere, made by Immunogen, Inc.), for adults with folate receptor alpha … Continued
Managing Diet for Ovarian Cancer
Many ovarian cancer patients and survivors wonder what the ideal diet for ovarian cancer may be. In a nutshell – there is no simple answer. In this article, adapted from … Continued
A Thanksgiving Message to Our Community
Dear Friends, I hope this finds you well. Whether you’re celebrating with loved ones today or holding them in your thoughts, my wish for you is that you’re feeling comfort … Continued
Ovarian Cancer from Beyond the Ovary: Perspectives on Science, Clinical Progress and Advocacy
“I don’t believe we can maximize our impact on ovarian cancer without embracing opportunities in other gynecologic cancers.” Dr. David Huntsman David Huntsman, MD, FRCPC, FCCMG, understands the field of … Continued